Jamil H. Muradov

Jamil H. Muradov

Auto-generated profile, based on publicly available information

Jamil H. Muradov

Department of Medical Neuroscience, Dalhousie University, Halifax, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2023 in Science Advances
Verified
Journal Article
Open access
Mark A. MacLeanMark A. MacLean
Mark A. MacLean
JMJamil H. Muradov
Jamil H. Muradov
RGRyan Greene
Ryan Greene
GHGerben Van Hameren
Gerben Van Hameren
DCDavid B. Clarke
David B. Clarke
AFAlon Friedman
Alon Friedman
Cortical spreading depolarization (CSD) is a promising target for neuroprotective therapy in traumatic brain injury (TBI). We explored the effect of NMDA receptor antagonism on electrically triggered CSDs in healthy and brain-injured animals. Rats received either one moderate or four daily repetitive mild closed head impacts (rmTBI). Ninety-three animals underwent craniectomy with electrocorticographic (ECoG) and local blood flow monitoring. In brain-injured animals, ketamine or memantine inhibited CSDs in 44 to 88% and 50 to 67% of cases, respectively. Near-DC/AC-ECoG amplitude was reduced by 44 to 75% and 52 to 67%, and duration by 39 to 87% and 61 to 78%, respectively. Daily memantine significantly reduced spreading depression and oligemia following CSD. Animals (N= 31) were randomized to either memantine (10 mg/kg) or saline with daily neurobehavioral testing. Memantine-treated animals had higher neurological scores. We demonstrate that memantine improved neurovascular function following CSD in sham and brain-injured animals. Memantine also prevented neurological decline in a blinded, preclinical randomized rmTBI trial.